Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable

This article affects  the problems of using NOAC in the most defenseless groups  of patients with atrial fibrillation: those  who have high bleeding and high thromboembolic risk and elderly. The focus is on comparison of effectiveness and safety of NOACs based  on randomized clinical trials (RCT) an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
Format: Artigo
Sprache:Inglês
Veröffentlicht: Stolichnaya Izdatelskaya Kompaniya 2018-11-01
Schriftenreihe:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Schlagworte:
atrial fibrillation
difficult patients
elderly
rivaroxaban
warfarin
Online Zugang:https://www.rpcardio.com/jour/article/view/1769
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge